4th Drug Discovery Re-Invented Conference, Bahamas, 2019

Conference themes
The fourth Drug Discovery Re-Invented Meeting brings together experts in medicinal chemistry, structure-based drug design, computational chemistry, emerging drug targets, and novel technology platforms. The meeting is extremely interactive with enthusiastic question and answer sessions following each talk. This meeting remains unique with respect to the breadth of participants and focus on new approaches to discovering drugs.

Professional congress organizer (PCO)
Fusion Conferences

Notes
Speakers: Vicky Steadman (Selcia Ltd), Jay Wrobel (FCCDC), Andrew Cole (Arbutus Bio), Vicki Feher (Schrodinger), Ted Price (CerSci Therapeutics), Christopher Savile (Intrexon), Bart DeCorte (Merachem), Matt Todd (Blumberg Institute)

Tickets: https://go.evvnt.com/224152-2?pid=4832 Booking: https://go.evvnt.com/224152-3?pid=4832

Conference Manager